TCM
IBRX icon

Traynor Capital Management’s ImmunityBio IBRX Stock Holding History

Traynor Capital Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,610
Closed -$47.8K – 372
2025
Q2 		$47.8K Sell
18,610
-13,490
-42% -$36.3K ﹤0.01% 249
2025
Q1 		$96.6K Buy
32,100
+500
+2% +$1.51K 0.01% 227
2024
Q4 		$80.9K Buy
31,600
+1,110
+4% +$4.62K 0.01% 256
2024
Q3 		$113K Sell
30,490
-210
-0.7% -$972 0.01% 247
2024
Q2 		$194K Buy
30,700
+8,200
+36% +$54.1K 0.01% 225
2024
Q1 		$121K Buy
22,500
+5,450
+32% +$24.7K 0.01% 239
2023
Q4 		$85.6K Buy
17,050
+2,100
+14% +$6.59K 0.01% 216
2023
Q3 		$25.3K Buy
+14,950
New +$30K ﹤0.01% 211

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return